Research ArticleOncology
Biodistribution, Radiation Dosimetry, and Clinical Application of a Melanin-Targeted PET Probe, 18F-P3BZA, in Patients
Xiaowei Ma, Shengjun Wang, Shuailiang Wang, Daliang Liu, Xiaohu Zhao, Hao Chen, Fei Kang, Weidong Yang, Jing Wang and Zhen Cheng
Journal of Nuclear Medicine January 2019, 60 (1) 16-22; DOI: https://doi.org/10.2967/jnumed.118.209643
Xiaowei Ma
1Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi’an, China; and
2Molecular Imaging Program at Stanford (MIPS), Bio-X Program, and Department of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford University, Stanford, California
Shengjun Wang
1Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi’an, China; and
Shuailiang Wang
1Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi’an, China; and
Daliang Liu
1Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi’an, China; and
Xiaohu Zhao
1Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi’an, China; and
Hao Chen
2Molecular Imaging Program at Stanford (MIPS), Bio-X Program, and Department of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford University, Stanford, California
Fei Kang
1Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi’an, China; and
Weidong Yang
1Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi’an, China; and
Jing Wang
1Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi’an, China; and
Zhen Cheng
2Molecular Imaging Program at Stanford (MIPS), Bio-X Program, and Department of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford University, Stanford, California
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 60, Issue 1
January 1, 2019
Biodistribution, Radiation Dosimetry, and Clinical Application of a Melanin-Targeted PET Probe, 18F-P3BZA, in Patients
Xiaowei Ma, Shengjun Wang, Shuailiang Wang, Daliang Liu, Xiaohu Zhao, Hao Chen, Fei Kang, Weidong Yang, Jing Wang, Zhen Cheng
Journal of Nuclear Medicine Jan 2019, 60 (1) 16-22; DOI: 10.2967/jnumed.118.209643
Biodistribution, Radiation Dosimetry, and Clinical Application of a Melanin-Targeted PET Probe, 18F-P3BZA, in Patients
Xiaowei Ma, Shengjun Wang, Shuailiang Wang, Daliang Liu, Xiaohu Zhao, Hao Chen, Fei Kang, Weidong Yang, Jing Wang, Zhen Cheng
Journal of Nuclear Medicine Jan 2019, 60 (1) 16-22; DOI: 10.2967/jnumed.118.209643
Jump to section
Related Articles
Cited By...
- 18F-PFPN PET: A New and Attractive Imaging Modality for Patients with Malignant Melanoma
- Advances in Receptor-Targeted Radiolabeled Peptides for Melanoma Imaging and Therapy
- Ultrasensitive detection of malignant melanoma using PET molecular imaging probes
- N-(2-(Dimethylamino)Ethyl)-4-18F-Fluorobenzamide: A Novel Molecular Probe for High-Contrast PET Imaging of Malignant Melanoma